MedPath

Functional Outcome Measures for Head and Neck Patients

Terminated
Conditions
Otorhinolaryngology Subjects Undergoing Free Flap Surgery
Registration Number
NCT02530112
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

The objective of this study is to identify outcome measures for cancer control in Head and Neck cancer patient populations at the University of Pennsylvania (HUP, PAH, Presby) by administering various functional outcome surveys and questionnaires about their reconstructive surgery. We hope to ultimately develop a QOL indicator that will reflect the impact of reconstructive surgery on patient's quality of life, and help with therapeutic interventions and explanation of expectations prior to surgery.

Detailed Description

Few studies examine quality of life outcome measures with initial diagnosis, surgical procedures,perioperative measures (such as use of perioperative blood transfusion or pressors), and outcomes for cancer control and free flap survival. This sub-protocol, in conjunction with protocol #816676 (Otorhinolaryngology Research Registry) will serve as a hypothesis generating study for future research on reconstructive free flap surgery outcomes by narrowing down existing questionnaires to tailor it specifically for these patients.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Subjects who have consented to Otorhinolaryngology Research Registry and are undergoing free flap surgery.
Exclusion Criteria
  • No children, pregnant women, or prisoners will be consented.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Completion of Survey9 years

Completion of quality of life surveys.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Abramson Cancer Center of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Abramson Cancer Center of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.